SFBC Anapharm announces the nomination of Ms. Isabel Desmarais as Assistant Chief Operating Officer
Ms Johane Boucher-Champagne, SFBC Anapharm’s Chief Operating Officer, is happy to announce the nomination of Ms Isabel Desmarais as Assistant Chief Operating Officer.
QUEBEC, May 6, 2005 -- Ms Johane Boucher-Champagne, SFBC Anapharm's Chief Operating Officer, is happy to announce the nomination of Ms Isabel Desmarais as Assistant Chief Operating Officer. Graduated in Pharmacy at the Universit Laval in 1995, Ms Desmarais also holds a Master in Hospital Pharmacy and a MBA in Business Management, completed in 2003 while working at SFBC Anapharm.
"Her expertise, her professionalism and her large contribution to SFBC Anapharm's business makes her the ideal candidate for this newly created job within our general management team. The dazzling expansion of our organization during the last years and the numerous challenges we have to face require excellence. I am therefore very happy to rely on such a quality person to help us in taking them up", declared Ms Boucher-Champagne
Since she joined SFBC Anapharm in 1998, Isabel Desmarais quickly got promotions within the company, being first a protocol writer, then a project manager and assistant director in our Scientific and Regulatory Affairs division. Having a strong 10-year experience in the pharmaceutical field, Isabel Desmarais has been acting as Project Management Director for 3 years at SFBC Anapharm, where she greatly contributed to the elaboration and development of many efficient and fast management programs and procedures for all critical aspects of studies and this, while respecting the highest quality standards.
Founded in Quebec in 1994, Anapharm, member of SFBC International, is the most important private contract research organisation specialized in phases I & II and bioequivalence tests in North America. The company offers leading services to pharmaceutical and biopharmaceutical companies all over the world. The company employs more than 700 specialists located in four sites in Quebec, its head office, in Montreal, Trois-Rivires and Toronto.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
